Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1803 studies found for:    "Diabetes Mellitus, Type 1"
Show Display Options
Rank Status Study
21 Completed Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)
Condition: Diabetes Mellitus, Type 1
Intervention: Behavioral: Resistance and/or Aerobic Exercise
22 Withdrawn Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: efalizumab;   Drug: placebo
23 Completed
Has Results
Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Diabetes Assistant (DiAs)
24 Completed Influence of Vitamin D on Vascular Function in Adolescents and Young Adults With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Dietary Supplement: Vitamin D
25 Completed Proleukin and Rapamune in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: IL-2;   Drug: sirolimus
26 Recruiting Motivational Interview in Adolescents With Poorly Controlled Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Behavioral: Motivational Interviewing;   Behavioral: Standard Education
27 Completed CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Continuous glucose monitoring with DexCom G4 platina
28 Recruiting Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Metabolic Challenge Admission;   Other: CGM home test
29 Active, not recruiting Young With Diabetes Type 1 - Test of an mHealth App
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Young with Diabetes - app
30 Terminated Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Biological: otelixizumab
31 Completed
Has Results
Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy
Condition: Diabetes Mellitus, Type 1
Interventions: Behavioral: Education by structured programme;   Device: CSII;   Device: CGM-RT;   Procedure: Screening for Complications;   Procedure: Glycaemic control assessment;   Procedure: QoL assessment;   Procedure: Knowledge assessment
32 Completed
Has Results
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB);   Drug: Placebo control for Mycophenolate mofeteil (MMF);   Drug: Placebo control for Daclizumab (DZB)
33 Not yet recruiting Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Other: 24-hour inpatient intervention;   Other: Exercise sub-study intervention;   Other: Meal sub-study intervention
34 Unknown  Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Polyclonal anti-T-cell antibodies
35 Completed Mini-Dose Glucagon for Adults With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: G-Pen Mini™ (glucagon injection);   Other: Diachieve Glucose Tabs
36 Completed
Has Results
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Anti-CD3 mAb;   Other: Diabetes Standard of Care Treatment;   Dietary Supplement: Iron supplementation
37 Unknown  Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: rituximab
38 Completed
Has Results
Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Dietary Supplement: Medium chain fatty acid (Octanoic and Decanoic acid);   Other: Splenda (Placebo Control)
39 Active, not recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
40 Active, not recruiting DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: GAD-Alum (Diamyd) 20 µg;   Biological: GAD-Alum (Diamyd) 20 µg X 2;   Drug: Vitamin D;   Drug: Ibuprofen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.